FDA Investigator: Ephrem T. Hunde

- Ephrem T. Hunde first started conducting FDA inspections in 2016, with the last inspection in 2024. Over that time, Ephrem T. Hunde has conducted 10 inspections at 10 companies across 10 sites.

Get Ephrem Hunde's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Shenzhen Lantern Science Co., Ltd., Shenzhen | 2024

Out-of-stock
Ephrem T. Hunde
Human Drugs Form 483

FDA 483 Sunshine Lake Pharma Co., Ltd, Dongguan | 2024

Out-of-stock
Ephrem T. Hunde
Human Drugs Form 483

FDA 483 BSP Pharmaceuticals Srl, Latina | 2018

Out-of-stock
Ephrem T. Hunde
Human Drug Form 483

FDA 483 Biogen U.S. Corporation, Research Triangle Park | 2018

Out-of-stock
Ephrem T. Hunde
Human Drug Form 483

FDA 483 Boehringer Ingelheim Fremont, Inc., Fremont | 2017

Out-of-stock
Ephrem T. Hunde
Human Drug Form 483

FDA 483 Cangene BioPharma, LLC dba Emergent BioSolutions, Baltimore | 2017

Out-of-stock
Ephrem T. Hunde
Human Drug Form 483

FDA 483 Biogen Idec (Denmark) Manufacturing ApS, Hillerod | 2016

Out-of-stock
Ephrem T. Hunde
Human Drug Form 483

FDA 483 UCB Pharma S.A., Braine-l'alleud | 2016

Out-of-stock
Ephrem T. Hunde
Human Drug Form 483